NASDAQ:SRNE
Delisted
Sorrento Therapeutics Stock News
$0.307
+0 (+0%)
At Close: Feb 23, 2023
Do Options Traders Know Something About Sorrento (SRNE) Stock We Don't?
09:47am, Tuesday, 19'th Jan 2021
Investors need to pay close attention to Sorrento (SRNE) stock based on the movements in the options market lately.
Dr. Henry Ji to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 20, 2021
02:06am, Tuesday, 19'th Jan 2021
SAN DIEGO, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming con
SRNE Stock Price: $30 Target From H.C. Wainwright
05:38pm, Sunday, 17'th Jan 2021
The stock price of Sorrento Therapeutics Inc (NASDAQ: SRNE) has received a price target of $30 from H.C. Wainwright.
These Nasdaq Biotech Stocks Doubled in 2020. Here's Why They're Soaring on Friday
03:55pm, Friday, 15'th Jan 2021
Success tends to bring more success.
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
05:58pm, Sunday, 10'th Jan 2021
SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming con
Sorrento Therapeutics (SRNE) Stock Sinks As Market Gains: What You Should Know
06:48pm, Wednesday, 06'th Jan 2021
Sorrento Therapeutics (SRNE) closed the most recent trading day at $7.03, moving -0.57% from the previous trading session.
SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that a Marketing Authorization Application has been submitted by its agents in Mexic
COVID News Flow: Pfizer-BioNTech's US Vaccine Supply Deal, Merck Strikes $356M Contract, Sorrento Files For EUA Of Rapid Test
01:53pm, Wednesday, 23'rd Dec 2020
COVID-19-related developments headlined biotech news flow on Wednesday, with announcements of a couple of federal deals and a filing for emergency use authorization. Pfizer-BioNTech to Supply U.S. 100
Sorrento Therapeutics developing antibodies injection and nose drops to fight Covid-19
08:41am, Wednesday, 23'rd Dec 2020
Sorrento Therapeutics is developing an antibodies injection and nose drops to fight Covid-19 and its variant strains.
SAN DIEGO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that an Emergency Use Authorization (EUA) Application has been submitted to the US F
Sorrento Stock Is Little More Than a Day Trade Now
04:32pm, Monday, 21'st Dec 2020
Nearly a third of SRNE stock's float has been sold short. This sets up a catalyst for a short-term move, but avoid a long-term investment.
Government and Institutional Support Are Positives for Sorrento Stock
06:01am, Thursday, 10'th Dec 2020
Sorrento just received a grant of up to $34 million from Washington, while multiple institutions own meaningful amounts of SRNE stock. The post Government and Institutional Support Are Positives for S
Sorrento Therapeutics Cleared to Start Trial for Its Next-Generation Coronavirus Antibody Treatment
01:27pm, Wednesday, 09'th Dec 2020
The new version is more potent, and therefore requires a lower dose.
Why Sorrento And Infinity Are Moving Today
12:25pm, Wednesday, 09'th Dec 2020
Sorrento Therapeutics (NASDAQ: SRNE) shares are trading higher on Wednesday after the company announced it has received CLIA Licensure from the State of California that permits testing of clinical sam
SRNE Stock: California Testing Approval Stokes Sorrento Therapeutics
09:26am, Wednesday, 09'th Dec 2020
Sorrento Therapeutics is poised to roll out clinical testing trials in California. SRNE stock is up in pre-market trading on Wednesday as the country continues to post record Covid-19 diagnoses and ho
